Skip to main content
main-content

Respiratory

Editor's pick

Most patients with asthma will not experience an exacerbation

Asthma attack_woman

Only a third of patients with asthma will experience an exacerbation, show 7 years of observation in more than 50,000 adults with the condition.

17-01-2019 | Asthma | News | Article

Better adherence with once- than twice-daily ICS/LABA therapy in asthma patients

Patients with asthma who are treated with the once-daily inhaled corticosteroid/long-acting beta agonist regimen fluticasone furoate/vilanterol have better treatment adherence than those taking the twice-daily budesonide/formoterol combination, researchers report.

Source:

J Allergy Clin Immunol Pract 2019; doi:10.1016/j.jaip.2018.12.021

10-01-2019 | Respiratory | News | Article

Further investigation of omeprazole warranted in patients with IPF

The proton pump inhibitor omeprazole is well tolerated and may reduce cough frequency in patients with idiopathic pulmonary fibrosis, suggest results from a pilot phase II trial.

Source:

Thorax 2019; doi:10.1136/thoraxjnl-2018-212102

20-12-2018 | Asthma | News | Article

Genetic variants linked to moderate-to-severe asthma susceptibility

A genome-wide association study has identified novel genetic variants associated with the risk of developing moderate-to-severe asthma, a substantial proportion of which are also associated with mild asthma susceptibility.

Source:

Lancet Respir Med 2018; doi:10.1016/S2213-2600(18)30389-8
Lancet Respir Med 2018; doi:10.1016/S2213-2600(18)30447-8

18-12-2018 | Asthma | News | Article

Blood eosinophil variability has treatment decision effects

Researchers have highlighted the need for blood eosinophils to be repeatedly measured in patients with severe asthma when designating treatment having found that levels vary in individuals over time.

Source:

Clin Exp Allergy 2018; doi:10.1111/cea.13310

Twitter Icon Follow medwireNews

Click here
image credits